The significant role of telomerase activity in human brain tumors

Cancer

Volumn 80, Issue 3, 1997, Pages 471-476

  Nakatani, Kei ^a   Yoshimi, Naoki ^a   Mori, Hideki ^a   Yoshimura, Shin Ichi ^a   Sakai, Hideki ^a   Shinoda, Jun ^a   Sakai, Noboru ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glioblastoma multiforme; Human brain tumor; Oligodendroglioma; Prognosis; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TELOMERASE;

EID: 0030862763     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970801)80:3<471::AID-CNCR15>3.0.CO;2-U     Document Type: Article

References (27)

1. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990;345:458-60.
3. Levy MZ, Allsopp RC, Futcher B, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-60.
4. Shay JW, Wright WE, Brasiskyte D, Van Der Haegen BA. E6 of human papilomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 1993;8:1407-13.
5. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-8.
6. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
7. Counter CM, Avillion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
8. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-9.
9. Counter CM, Hirte HW, Bacchetti S, Harely CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-4.
10. Counter CM, Guptta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematological malignancies. Blood 1995;9:2315-20.
11. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994;9:3043-8.
12. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
13. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcome. Nat Med 1995;1:249-55.
14. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
15. Langford LA, Piatyszek MA, Schold SCJ, Shay JW. Telomerase activity in human brain tumours. Lancet 1995;346:1267-8.
16. Meihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. In: World Health Organization. International histological classification of tumors. 2nd edition. Berlin: Springer-Verlag, 1993:5-17.
17. Yoshimi N, Ino N, Suzui M, Hara A, Nakatani K, Mori H, et al. Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues. Mol Carcinog 1996;16:1-5.
18. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41.
19. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991;1072:1-7.
20. Shay JW, Werbin H, Wright WE. Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Differ 1994;2:1-21.
21. Lindsey J, McGill NI, Lindsey LA, Gree DK, Kooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256:45-8.
22. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EV. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987;255:1394-9.
23. Frankel RH, Bayona W, Koslow M, Newcomb EW. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 1992; 52:1427-33.
24. He J, Allen JR, Colins VP, Allalunis-Turner MJ, Godbout R, Day RS 3rd, et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell line. Cancer Res 1994;54:5804-7.
25. Rasheed BKA, Bigner SH. Genetic alterations in glioma and medulloblastoma. Cancer Metastasis Rev 1991;10:289-99.
26. Russell D, Rubinstein LJ. Pathology of tumors of the nervous system. 5th edition. London: Edward Arnold, 1989.
27. Burger PC, Shibata T, Kleihues P. The use of monoclonal antibody Ki-67 in identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 1986; 10:611-7.